MedPath

ONO-7914

Generic Name
ONO-7914

Study of ONO-7914 Alone and in Combination With ONO-4538 in Patients With Solid Tumors

Phase 1
Active, not recruiting
Conditions
Solid Tumor
Interventions
First Posted Date
2024-08-02
Last Posted Date
2025-02-21
Lead Sponsor
Ono Pharmaceutical Co. Ltd
Target Recruit Count
204
Registration Number
NCT06535009
Locations
🇯🇵

Cancer Institute Hospital of JFCR, Koto-ku, Tokyo, Japan

© Copyright 2025. All Rights Reserved by MedPath